InsidersTradesSigma
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Traversa Sergio. Director active across 1 company, notably Relmada Therapeutics, INC.. In total, 8 filings have been published. Split: 7 buys · 0 sell. Total volume traded: €1.1m. Activity tracked since 30 June 2022. The latest transaction was filed on 15 December 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
TRAVERSA SERGIO is a declarant with 8 filings in total. In the 8 sampled recent filings, all linked to Relmada Therapeutics, INC. (XNAS) where he is Chief Executive Officer, buys amount to EUR 1085152 and sells to EUR 0, with a period running from 2022-07-05 to 2025-12-16. The modal transaction nature is Acquisition.